Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Erin Schenk"'
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Inhibitory antibodies targeting programmed death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) have resulted in improved outcomes for many patients with metastatic non-small cell lung cancer in (NSCLC) in the second-line setting due to their
Externí odkaz:
https://doaj.org/article/0fe350ac38ca418391a06dd0cafc21b3
Autor:
Dwight H. Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B. Leighl, Hirva Mamdani, Gregory Masters, Pamela R. Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J. Riely, Andrew G. Robinson, Erin Schenk, Bryan J. Schneider, Lecia Sequist, David R. Spigel, Ishmael A. Jaiyesimi
Publikováno v:
Journal of Clinical Oncology. 41:e10-e20
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6e3504714a46492267682c508eb5387
https://doi.org/10.1200/jco.22.02124
https://doi.org/10.1200/jco.22.02124
Autor:
Raphael Nemenoff, Emily Kleczko, Trista Hinz, Andre Navarro, Anh Le, Teresa Nguyen, Natalia Gurule, Amber Johnson, Jeff Kwak, Diana Polhac, Eric Clambey, Mary Weiser-Evans, Daniel Merrick, Michael Yang, Tejas Patil, Erin Schenk, Lynn Heasley
Lung cancers bearing oncogenic EML4-ALK fusions respond to targeted tyrosine kinase inhibitors (TKIs; e.g. alectinib), with variation in the degree of shrinkage and duration of treatment (DOT). However, factors that control this response are not well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af07c9bbb2b5566a16db5514a3a4e76a
https://doi.org/10.21203/rs.3.rs-2136258/v1
https://doi.org/10.21203/rs.3.rs-2136258/v1
Publikováno v:
Oncology (Williston Park, N.Y.). 33(3)
Lung cancer is the leading cause of cancer death in the United States and worldwide. While most patients present with advanced metastatic disease for which a cure is elusive, increased use of spiral CT screening has led to identification of more earl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0db3100369785eb984dc40102cdc0775
https://pubmed.ncbi.nlm.nih.gov/30866032
https://pubmed.ncbi.nlm.nih.gov/30866032